Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford uni                                                                      

Dr Philip Drennan – Chief Investigator

Dr Huda Fadzillah – Consultant



Immune Responses to Modified Vaccinia Ankara Vaccine (IMOVA) Study


People who are receiving a vaccine against monkeypox are being invited to participate in the IMOVA Study.


The IMOVA Study involves looking at how the body’s immune system responds to the vaccine.

The study is run by a team of doctors, nurses and scientists working together across the Oxford University Hospitals NHS Foundation Trust and the University of Oxford.

When you attend your vaccine appointment, you may be approached about the study.   If you think you would like to take part, please contact the study team below.  They may arrange for you to attend your appointment at a slightly earlier time since they would need to go through the information with you before you have the vaccine.

Taking part in the study involves having some blood samples taken and coming back into the clinic for some extra visits.  The study team will also ask you to complete some questionnaires.

If you would like to know more about it, please see information below and please contact the study team (details below)

Renumeration for time and travel expenses reimbursement will be offered.

If you do not wish to take part in the study, this will not affect your routine care in the vaccine clinic.



Vaccine Team

Oxford University Hospitals NHS Foundation Trust




You can download the deatil of the study from here.